Technical analysis of Bolt Biotherapeutics, Inc. (BOLT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2).
Price Performance
| 1 month | +14.15% |
| 3 months | -9.02% |
| Year-to-date | -33.64% |
| 1 year | -32.40% |
| 3 years | -83.50% |
| 5 years | -98.81% |
52-Week Range
| 52-week High | $7.20 |
| 52-week Low | $3.13 |
| Avg Volume (90d) | 26K |
Technical Indicators
| SMA 50 | $3.85 |
| SMA 200 | $4.70 |
| Beta | 0.86 |
| 30-day Volatility (annualised) | 81.3% |
| Price vs SMA 50 | -5.7% |
| Price vs SMA 200 | -22.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $5.76 | |
| 2025-11 | $5.07 | -12.0% |
| 2025-12 | $5.47 | +7.9% |
| 2026-01 | $5.90 | +7.9% |
| 2026-02 | $4.52 | -23.4% |
| 2026-03 | $4.04 | -10.6% |
| 2026-04 | $4.80 | +18.8% |
| 2026-05 | $5.25 | +9.4% |
| 2026-06 | $3.85 | -26.7% |
| 2026-07 | $3.99 | +3.6% |
| 2026-08 | $3.98 | -0.3% |
| 2026-09 | $3.63 | -8.8% |
Price
| Price | $3.63 |
| Market Cap | $7M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.49 |
| EV / EBITDA | -0.67 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 1.71 |
| Current Ratio | 2.61 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -12.58 |